No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
CGNX240719C40000
- 12.75
- 0.000.00%
15min DelayTrading Jul 16 11:09 ET
0.00High0.00Low
0.00Open12.75Pre Close0 Volume3 Open Interest40.00Strike Price0.00Turnover227.66%IV0.84%PremiumJul 19, 2024Expiry Date12.31Intrinsic Value100Multiplier2DDays to Expiry0.44Extrinsic Value100Contract SizeAmericanOptions Type0.9355Delta0.0129Gamma4.18Leverage Ratio-0.2184Theta0.0025Rho3.91Eff Leverage0.0054Vega
Intraday
- 5D
- Daily
News
Cognex Announces Second Quarter 2024 Earnings Release and Conference Call Dates
NATICK, Mass., July 12, 2024 /PRNewswire/ -- Cognex Corporation (NASDAQ: CGNX) will release earnings for the second quarter of 2024 on Wednesday, July 31, 2024, after market close.The Company will
Truist Financial Maintains Cognex(CGNX.US) With Buy Rating, Maintains Target Price $55
Truist Financial analyst Jamie Cook maintains $Cognex(CGNX.US)$ with a buy rating, and maintains the target price at $55.According to TipRanks data, the analyst has a success rate of 60.9% and a
Truist Financial Sticks to Its Buy Rating for Cognex (CGNX)
Analyst Expectations For Cognex's Future
9 analysts have expressed a variety of opinions on Cognex (NASDAQ:CGNX) over the past quarter, offering a diverse set of opinions from bullish to bearish.In the table below, you'll find a summary of t
Cognex Is Maintained at Buy by Truist Securities
Cognex Is Maintained at Buy by Truist Securities
Truist Financial Maintains Cognex(CGNX.US) With Buy Rating, Raises Target Price to $55
Truist Financial analyst Jamie Cook maintains $Cognex(CGNX.US)$ with a buy rating, and adjusts the target price from $50 to $55.According to TipRanks data, the analyst has a success rate of 60.7% and
Comments
The diminishing returns on increasing amounts of capital at Cognex are concerning. Unless there is a shift to a more positive trajectory in these metrics, it would be advisable to look elsewhere for investment opportunities.
The Returns On Capital At Cognex (NASDAQ:CGNX) Don't Inspire ConfidenceCognex's high P/E ratio amid falling earnings signifies investor's hopes for company's recovery. However, current prices could pose risk to share price if no significant improvement is seen.
1
Pre-Market Stock Movers
Gapping up
$NVIDIA(NVDA.US$ stock rose 0.4%, adding more gains after the chipmaker recorded its highest-ever closing price on Tuesday, as it has become the focal point of a recent surge in enthusiasm around the applications of generative artificial intelligence.
Gapping down
$HP Inc(HPQ.US$ stock fell 8.3% after the information technology company tempered expectations for annual profit, as it g...
Gapping up
$NVIDIA(NVDA.US$ stock rose 0.4%, adding more gains after the chipmaker recorded its highest-ever closing price on Tuesday, as it has become the focal point of a recent surge in enthusiasm around the applications of generative artificial intelligence.
Gapping down
$HP Inc(HPQ.US$ stock fell 8.3% after the information technology company tempered expectations for annual profit, as it g...
17
2
Gapping up
In reaction to earnings/guidance:
• $Cognex(CGNX.US$ +5.4%, $Apogee Enterprises(APOG.US$ +1.7%
Other news:
• $Roivant Sciences(ROIV.US$ +12.3% (files $1 bln mixed securities shelf offering)
• $Change Healthcare(CHNG.US$ +7.5% (a federal judge ruled against the Justice Department’s antitrust challenge to $UnitedHealth(UNH.US$ planned $13 billion acquisition of the company)
• $Perpetua Resources(PPTA.US$ +6.1% (receiv...
In reaction to earnings/guidance:
• $Cognex(CGNX.US$ +5.4%, $Apogee Enterprises(APOG.US$ +1.7%
Other news:
• $Roivant Sciences(ROIV.US$ +12.3% (files $1 bln mixed securities shelf offering)
• $Change Healthcare(CHNG.US$ +7.5% (a federal judge ruled against the Justice Department’s antitrust challenge to $UnitedHealth(UNH.US$ planned $13 billion acquisition of the company)
• $Perpetua Resources(PPTA.US$ +6.1% (receiv...
12
Read more